161 related articles for article (PubMed ID: 35411835)
1. Tumor targetable and pH-sensitive polymer nanoparticles for simultaneously improve the Type 2 Diabetes Mellitus and malignant breast cancer.
Tang S; Wen P; Li K; Deng J; Yang B
Bioengineered; 2022 Apr; 13(4):9754-9765. PubMed ID: 35411835
[TBL] [Abstract][Full Text] [Related]
2. Loading studies of the anticancer drug camptothecin into dual stimuli-sensitive nanoparticles. Stability scrutiny.
Iglesias N; Galbis E; Díaz-Blanco MJ; de-Paz MV; Galbis JA
Int J Pharm; 2018 Oct; 550(1-2):429-438. PubMed ID: 30196142
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
[TBL] [Abstract][Full Text] [Related]
4. Glucose-conjugated glutenin nanoparticles for selective targeting and delivery of camptothecin into breast cancer cells.
Rajeshkumar RR; Pavadai P; Panneerselvam T; Deepak V; Pandian SRK; Kabilan SJ; Vellaichamy S; Jeyaraman A; Kumar ASK; Sundar K; Kunjiappan S
Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2571-2586. PubMed ID: 37022437
[TBL] [Abstract][Full Text] [Related]
5. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of camptothecin loaded polymer stabilized nanoemulsion: Targeting potential in 4T1-breast tumour xenograft model.
Sugumaran A; Ponnusamy C; Kandasamy P; Krishnaswami V; Palanichamy R; Kandasamy R; Lakshmanan M; Natesan S
Eur J Pharm Sci; 2018 Apr; 116():15-25. PubMed ID: 28987538
[TBL] [Abstract][Full Text] [Related]
7. Silver Nanoparticles Covered with pH-Sensitive Camptothecin-Loaded Polymer Prodrugs: Switchable Fluorescence "Off" or "On" and Drug Delivery Dynamics in Living Cells.
Qiu L; Li JW; Hong CY; Pan CY
ACS Appl Mater Interfaces; 2017 Nov; 9(46):40887-40897. PubMed ID: 29088537
[TBL] [Abstract][Full Text] [Related]
8. Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for "on-demand" drug delivery.
Qu Y; Chu B; Wei X; Lei M; Hu D; Zha R; Zhong L; Wang M; Wang F; Qian Z
J Control Release; 2019 Feb; 296():93-106. PubMed ID: 30664976
[TBL] [Abstract][Full Text] [Related]
9. Development of pH-Sensitive Cationic PEGylated Solid Lipid Nanoparticles for Selective Cancer-Targeted Therapy.
Chuang CH; Wu PC; Tsai TH; Fang YP; Tsai YH; Cheng TC; Huang CC; Huang MY; Chen FM; Hsieh YC; Lin WW; Tsai MJ; Cheng TL
J Biomed Nanotechnol; 2017 Feb; 13(2):192-03. PubMed ID: 29377649
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery.
Cirpanli Y; Bilensoy E; Lale Doğan A; Caliş S
Eur J Pharm Biopharm; 2009 Sep; 73(1):82-9. PubMed ID: 19442723
[TBL] [Abstract][Full Text] [Related]
11. A Multifunctional Nanotherapy for Targeted Treatment of Colon Cancer by Simultaneously Regulating Tumor Microenvironment.
Zhang Q; Zhang F; Li S; Liu R; Jin T; Dou Y; Zhou Z; Zhang J
Theranostics; 2019; 9(13):3732-3753. PubMed ID: 31281510
[TBL] [Abstract][Full Text] [Related]
12. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
Zhang X; Li F; Guo S; Chen X; Wang X; Li J; Gan Y
Biomaterials; 2014 Apr; 35(11):3650-65. PubMed ID: 24462359
[TBL] [Abstract][Full Text] [Related]
13. Dual sensitive and temporally controlled camptothecin prodrug liposomes codelivery of siRNA for high efficiency tumor therapy.
Li Y; Liu R; Yang J; Ma G; Zhang Z; Zhang X
Biomaterials; 2014 Dec; 35(36):9731-45. PubMed ID: 25189519
[TBL] [Abstract][Full Text] [Related]
14. Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing.
Ao M; Yu F; Li Y; Zhong M; Tang Y; Yang H; Wu X; Zhuang Y; Wang H; Sun X; Hong X; Chen XD
J Nanobiotechnology; 2021 Oct; 19(1):350. PubMed ID: 34717646
[TBL] [Abstract][Full Text] [Related]
15. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
[TBL] [Abstract][Full Text] [Related]
16. Improved tumor targeting and antitumor activity of camptothecin loaded solid lipid nanoparticles by preinjection of blank solid lipid nanoparticles.
Jang DJ; Moon C; Oh E
Biomed Pharmacother; 2016 May; 80():162-172. PubMed ID: 27133053
[TBL] [Abstract][Full Text] [Related]
17. A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug.
He W; Jiang Y; Li Q; Zhang D; Li Z; Luan Y
Acta Biomater; 2019 Jan; 84():356-366. PubMed ID: 30502480
[TBL] [Abstract][Full Text] [Related]
18. Poly(omega-pentadecalactone-co-butylene-co-succinate) nanoparticles as biodegradable carriers for camptothecin delivery.
Liu J; Jiang Z; Zhang S; Saltzman WM
Biomaterials; 2009 Oct; 30(29):5707-19. PubMed ID: 19632718
[TBL] [Abstract][Full Text] [Related]
19. Oral insulin delivery by epithelium microenvironment-adaptive nanoparticles.
Li J; Qiang H; Yang W; Xu Y; Feng T; Cai H; Wang S; Liu Z; Zhang Z; Zhang J
J Control Release; 2022 Jan; 341():31-43. PubMed ID: 34793919
[TBL] [Abstract][Full Text] [Related]
20. 5-Boronopicolinic acid-functionalized polymeric nanoparticles for targeting drug delivery and enhanced tumor therapy.
Hao X; Gai W; Wang L; Zhao J; Sun D; Yang F; Jiang H; Feng Y
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 119():111553. PubMed ID: 33321617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]